RIPK1 and cancer: While many studies have demonstrated that necroptosis-mediated inflammatory cell death can promote antitumor immune responses163,180,181, it has also been reported that RIPK1 activity regulates tumor immunity by reprogramming tumor-associated macrophages in some cancers, independent of RIPK3157,182.